Adalimumab: a new modality for Behçet's disease?

J A M van Laar, T Missotten, P L A van Daele, A Jamnitski, G S Baarsma, P M van Hagen

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)565-6
Number of pages2
JournalAnnals of the Rheumatic Diseases
Issue number4
Publication statusPublished - Apr 2007


  • Adalimumab
  • Adult
  • Antibodies, Monoclonal/therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents/therapeutic use
  • Behcet Syndrome/drug therapy
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors

Cite this